More than a third of malaria drugs in Southeast Asia, Africa are fake or poor quality

Latest News

Fake malaria drugs litter Southeast Asia, Africa Study: US clears drugs faster than Europe, Canada French trial opens in diabetes-diet drug scandal AIDS fight enters new phase with prevention pill News Summary: FDA panel backs diet drug lorcaserin

Buy AP Photo Reprints

Interactives

	Right at Home: Contemporary Furniture
	Right at Home: New craftsmanship
	Right at Home: Mother's Day gift ideas
	Right at Home: Home office
	Right at Home: Mirrors
	Right at Home: Cool kitchen tools
	Right at Home: Casual dining
	Right at Home: Kids decor
	Right at Home: Cozy, comfort decor
	Right at Home: Art deco in the home
	Right at Home: Machine shop chic
	Right at Home: Rugs
	Right at Home: Wallpaper
	Right at Home: Recycled products
	Right at Home: Metallic finishes
	Right at Home: Yellow decor
	Right At Home: Side tables
	Right at Home: Technology
	Right at Home: Cutouts
	Right at Home: Outdoor entertaining
	Right at Home: Recycled wood
	Right at Home: Outdoor furniture
	Right at Home: Stone decor

Multimedia

Drug war interactive

HANOI, Vietnam (AP) -- A study says more than a third of malaria-fighting drugs tested over the past decade in Southeast Asia and sub-Saharan Africa were either fake or bad quality.

The study published Tuesday says bogus and badly made drugs are threatening to upend a decade of progress fighting the mosquito-transmitted disease.

Fake drugs can lead to deaths because they contain no malaria-fighting agents. Pills without enough of the active ingredient to kill all malaria parasites are problematic because they increase drug resistance. That means malaria eventually will outsmart medicines and render them useless.

Exclusive News

Monday, May 21, 2012

More than a third of malaria drugs in Southeast Asia, Africa are fake or poor quality - @AP